Drug intelligence / Profile preview

panaxytriol

Development stage
Preclinical
Lead developer
Johns Hopkins University
Modality
Small Molecules
Administration
Oral
01

Overview

Panaxytriol is an unsaturated fatty alcohol classified as a polyacetylene compound and found naturally in the roots of Panax ginseng—specifically Korean red ginseng[2][3][4][11]. It is a bioactive constituent that has demonstrated significant anti-tumor and anti-inflammatory properties, including inhibition of several human cancer cell lines such as gastric carcinoma, lymphoma, breast carcinoma, and melanoma, in both in vitro and in vivo studies[3][7][9]. Mechanistically, panaxytriol acts in part by inducing phase 2 detoxification enzymes, such as quinone reductase, which contribute to cytoprotection against toxic insults and chemoprevention by promoting cellular defense responses to electrophiles and oxidative stress[1][3][5][7]. Additional activities include modulation of cytochrome P450 3A enzymes (CYP3A), affecting drug metabolism and possibly chemotherapeutic tolerance[2][5]. Panaxytriol has moderate neurotrophic activity and minimal toxicity at cytoprotective doses; analogs of the compound have exhibited increased potency without increased toxicity[3][9].

Other names
panaxytriol1-heptadecene-4,6-diyne-3,9,10-triolheptadec-1-en-4,6-diyne-3,9,10-triolfalcarintriol
02

Targets

CYP3A4 (Cytochrome P450 3A4)PXR (Pregnane X receptor)

Beyond the preview

Go deeper on panaxytriol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on panaxytriol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call